Lifitegrast

Lifitegrast Eye Drops in Healthy Subjects：Phase I Study

Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic Conjunctivitis

A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)

Safety Study of Lifitegrast to Treat Dry Eye

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease

Use of 5.0% Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease in Contact Lens Wearers

Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days

The Effect Of Lifitegrast On Refractive Accuracy And Symptoms In Dry Eye Patients Undergoing Cataract Surgery

Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease